相关实验视频
Updated: May 22, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
在CKD中认知功能障碍和痴呆症的遗传和循环生物标志物
Carmine Zoccali1,2,3, Francesca Mallamaci4,5, Carsten A Wagner6
1Renal Research Institute, NY, USA.
概括
认知能力下降在慢性病 (CKD) 中很常见. 研究强调了功能标志物,遗传因素和痴呆风险之间的联系,但需要更多的研究来理解这些复杂的关系.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
- 遗传学 遗传学 是一个
背景情况:
- 慢性病 (CKD) 经常与认知功能障碍和痴呆症同时发生.
- 这种认知障碍增加了住院,心血管事件和死亡的风险.
- 关于CKD和功能衰竭 (KF) 中认知障碍的遗传标志物存在重大研究差距.
研究的目的:
- 审查关于CKD和功能衰竭 (KF) 认知障碍的现有文献.
- 确定病标志物与认知功能之间的关联.
- 探索潜在的遗传倾向和与慢性病患者认知能力下降相关的生物标志物.
主要方法:
- 对调查CKD和KF认知功能的研究的文献综述.
- 分析功能标志物 (例如,eGFR,cystatin C,albuminuria) 和认知结果之间的关联.
- 在CKD/KF群体中检查与阿尔茨海默病和痴呆相关的报告生物标志物.
主要成果:
- 关于CKD/KF认知障碍遗传标记的研究有限.
- 在病标志物 (eGFR下降,白蛋白尿) 和认知恶化,包括血管痴呆和执行功能障碍之间建立了联系.
- 许多生物标志物 (粉样β,蛋白,尿素毒素,肠道微生物群,炎症) 与CKD/KF的认知问题有关,尽管因果关系尚不清楚.
结论:
- 认知障碍是CKD/KF的一个重要并发症.
- 功能标志物和各种生物因素与认知能力下降有关.
- 进一步的研究对于澄清CKD中生物标志物和认知健康之间的复杂相互作用和因果关系至关重要.
更多相关视频
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
46
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
46
01:26Alzheimer's Disease: Overview
409
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
409
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
88
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
88
01:30Dementia
82
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
82
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K